PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mdi324 ◽

2005 ◽

Vol 16 (10) ◽

pp. 1654-1661 ◽

Author(s):

S.R. Alberts ◽

N.R. Foster ◽

R.F. Morton ◽

J. Kugler ◽

P. Schaefer ◽

...

Keyword(s):

Treatment Group ◽

Cancer Treatment ◽

Pancreatic Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

North Central ◽

Randomized Phase Ii ◽

Metastatic Pancreatic Adenocarcinoma

Download Full-text

Gemcitabine (Gem), cisplatin (Cis) and radiation therapy (RT) for patients with locally advanced pancreatic adenocarcinoma (ACA): A North Central Cancer Treatment Group (NCCTG) phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4121 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4121-4121

Author(s):

M. G. Haddock ◽

R. Swaminathan ◽

S. R. Alberts ◽

M. D. Hauge ◽

N. R. Foster ◽

...

Keyword(s):

Radiation Therapy ◽

Treatment Group ◽

Cancer Treatment ◽

Pancreatic Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

North Central ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Gemcitabine (Gem), cisplatin (Cis) and radiation therapy (RT) for patients with locally advanced pancreatic adenocarcinoma (ACA): A North Central Cancer Treatment Group (NCCTG) phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4121 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4121-4121 ◽

Author(s):

M. G. Haddock ◽

R. Swaminathan ◽

S. R. Alberts ◽

M. D. Hauge ◽

N. R. Foster ◽

...

Keyword(s):

Radiation Therapy ◽

Treatment Group ◽

Cancer Treatment ◽

Pancreatic Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

North Central ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

The Oncologist ◽

10.1634/theoncologist.2018-0878 ◽

2019 ◽

Vol 24 (5) ◽

pp. 589 ◽

Author(s):

Thorvardur R. Halfdanarson ◽

Nathan R. Foster ◽

George P. Kim ◽

Jeffrey P. Meyers ◽

Thomas C. Smyrk ◽

...

Keyword(s):

Treatment Group ◽

Cancer Treatment ◽

Randomized Trial ◽

Pancreatic Adenocarcinoma ◽

Phase Ii ◽

North Central ◽

Metastatic Pancreatic Adenocarcinoma ◽

Download Full-text

Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)

Journal for ImmunoTherapy of Cancer ◽

10.1186/2051-1426-3-s2-p155 ◽

2015 ◽

Vol 3 (S2) ◽

Author(s):

Dung T Le ◽

Todd S Crocenzi ◽

Jennifer N Urum ◽

Eric R Lutz ◽

Daniel A Laheru ◽

...

Keyword(s):

Immune Response ◽

Pancreatic Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Metastatic Pancreatic Adenocarcinoma ◽

Previously Treated

Download Full-text

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia: A phase II study from the North Central Cancer Treatment Group

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4059 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4059-4059 ◽

Author(s):

A. Jatoi ◽

B. Murphy ◽

N. Foster ◽

D. Nikcevich ◽

S. Alberts ◽

...

Keyword(s):

Treatment Group ◽

Cancer Treatment ◽

Phase Ii ◽

Phase Ii Study ◽

Gastroesophageal Junction ◽

Gastric Cardia ◽

Metastatic Adenocarcinoma ◽

North Central ◽

Adenocarcinoma Of The Esophagus ◽

Download Full-text

A randomized phase II trial of temozolomide (TMZ) and bevacizumab (BEV) or nab-paclitaxel (nab-P)/carboplatin (CBDCA) and bevacizumab (BEV) in patients with unresectable stage IV metastatic melanoma: A North Central Cancer Treatment Group Study (N0775).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8532 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8532-8532 ◽

Author(s):

L. A. Kottschade ◽

V. Suman ◽

D. G. Perez ◽

R. R. McWilliams ◽

J. S. Kaur ◽

...

Keyword(s):

Treatment Group ◽

Cancer Treatment ◽

Metastatic Melanoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iv ◽

North Central ◽

Randomized Phase Ii ◽

Unresectable Stage

Download Full-text

North Central Cancer Treatment Group Phase II Study of 5-Fluorouracil and High-Dose Levamisole for Gastric and Gastroesophageal Cancer Using Survival as the Primary Endpoint of Efficacy

American Journal of Clinical Oncology ◽

10.1097/00000421-199910000-00017 ◽

1999 ◽

Vol 22 (5) ◽

pp. 505 ◽

Author(s):

Patrick A. Burch ◽

Michael D. Keppen ◽

Georgene Schroeder ◽

Joseph Rubin ◽

James E. Krook ◽

...

Keyword(s):

Treatment Group ◽

Cancer Treatment ◽

Phase Ii ◽

Primary Endpoint ◽

Phase Ii Study ◽

High Dose ◽

Gastroesophageal Cancer ◽

Download Full-text

Gemcitabine and epirubicin in patients with malignant pleural mesothelioma (MPM): A North Central Cancer Treatment Group phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7264 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7264-7264 ◽

Author(s):

S. H. Okuno ◽

R. Delaune ◽

J. Sloan ◽

M.-C. Aubry ◽

N. Foster ◽

...

Keyword(s):

Treatment Group ◽

Cancer Treatment ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Study ◽

Pleural Mesothelioma ◽

Download Full-text

Randomized phase II study of the safety, efficacy, and immune response of GVAX pancreas vaccine (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps4148 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS4148-TPS4148 ◽

Author(s):

Dung T. Le ◽

Todd S. Crocenzi ◽

Jennifer N. Uram ◽

Eric R. Lutz ◽

Daniel A. Laheru ◽

...

Keyword(s):

Immune Response ◽

Pancreatic Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Metastatic Pancreatic Adenocarcinoma ◽

Previously Treated

Download Full-text

A Tomato-Based, Lycopene-Containing Intervention for Androgen-Independent Prostate Cancer: Results of a Phase II Study from The North Central Cancer Treatment Group

Urology ◽

10.1016/j.urology.2006.10.019 ◽

2007 ◽

Vol 69 (2) ◽

pp. 289-294 ◽

Author(s):

Aminah Jatoi ◽

Patrick Burch ◽

David Hillman ◽

Joanne M. Vanyo ◽

Shaker Dakhil ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Phase Ii ◽

Phase Ii Study ◽

North Central ◽

The North ◽

Androgen Independent

Download Full-text